Skip to main content
. 2026 Feb 2;18(2):194. doi: 10.3390/pharmaceutics18020194
AUC Area Under the Curve
BA Bioavailability
BE Bioequivalence
BRI Biopharmaceutics Research Institute
CHMP Committee for Medicinal Products for Human Use
Cmax Maximum Concentration
DPK Dermatopharmacokinetics
EMA European Medicines Agency
Emax Maximum Effect Model
FDA United States Food and Drug Administration
FS Fraction Absorbed into Skin
HSBA Human Skin Blanching Assay
HPLC High Performance Liquid Chromatography
Kin Rate of Drug Input into the Skin
MHLW Ministry of Health, Labour and Welfare (Japan)
MLEM Maximum Likelihood Expectation Maximization
PK Pharmacokinetics
SC Stratum Corneum
TEWL Transepidermal Water Loss
TS Tape Stripping